Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
LQDA
#1128
Liquidia Corporation - Common Stock
77.7
4
USD
+0.02%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+1.63%
Monthly Change
+8.47%
6 month change
+103.03%
Year Change
+243.98%
Previous Close
76.4
9
Open
76.9
0
Low
76.4
4
High
77.7
5
Volume
461
Markets
US Stock Market
Healthcare
Biotechnology
LQDA
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
Q1, 25
Q2, 25
Q3, 25
Q4, 25
Q1, 26
Current
Key stats
Total common shares outstanding
85.48 M
86.09 M
87 M
88.11 M
88.93 M
88.93 M
Valuation ratios
Enterprise value
1.09 B
899.28 M
1.82 B
2.85 B
3.13 B
6.9 B
Price to earnings ratio
-9.22
-7.24
-15.58
-43.11
222
471.21
Price to sales ratio
82
52.98
28.03
18.75
12.11
25.71
Price to cash flow ratio
-11.88
-8.86
-18.96
-83.17
81.38
172.74
Price to book ratio
3.88
3.95
11.38
66.33
18.62
39.52
Enterprise value to EBITDA ratio
-8.68
-6.59
-17.25
-57.14
66.49
146.43
Profitability ratios
Return on assets %
-0.17
-0.16
-0.01
0.04
0.13
0.13
Return on equity %
-0.77
-2.74
-0.16
0.33
0.49
0.49
Return on invested capital %
—
—
—
54.99
133.18
133.18
Gross margin %
51.38
100
100
100
100
100
Operating margin %
-1 135.42
-424.41
3.25
21.5
46.29
46.29
EBITDA margin %
-1 120.96
-421.23
4.13
21.85
46.66
46.66
Net margin %
-1 229.71
-470.51
-6.5
15.82
39.79
39.79
Liquidity ratios
Quick ratio
2.91
2.41
1.96
1.84
2.03
2.03
Current ratio
2.93
2.49
2.2
2.01
2.22
2.22
Inventory turnover
1.91
—
—
—
—
—
Asset turnover
0.01
0.03
0.2
0.3
0.36
0.36
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
-0.36
-0.46
-0.11
0.51
0.52
0.46
EBIT per share
-0.42
-0.44
0.02
0.23
0.61
0.42
EBITDA per share
-0.41
-0.43
0.03
0.23
0.61
0.44
Total debt per share
—
—
—
—
—
—
Cash per share
1.99
2.03
1.82
2.22
2.2
2.2
Net current asset value per share
2.08
2.29
2.63
3.18
3.29
3.29
Tangible book value per share
0.58
0.18
0.26
0.52
1.07
1.07
Working capital per share
1.37
1.37
1.43
1.6
1.81
1.81
Book value per share
0.58
0.18
0.26
0.52
1.07
1.07
News
AZN Inks Deal With Dizal to In-License Rights to Lung Cancer Drug
Summit to Divest Late-Stage Antibiotic Drug to Biossil in $105M Deal
AGEN Stock Jumps on Securing $340M Financing to Fund Strategic Pivot
GSK's Jemperli Delivers Promising Interim Data in Rectal Cancer
Can LQDA's Yutrepia Drive Growth in the Competitive PAH Market?
FDA Expands MRK & PFE's Keytruda-Padcev Combo Use in Bladder Cancer
CG Oncology Stock Gains 12% in Three Months: What's Driving It?
4 Low-Beta Stocks to Minimize Portfolio Risk: LQDA, FLXS, ELMD & AGX
Immunome Stock Up 32% in a Month: Here's What You Should Know
FBRX Stock Rallies 78% on Positive Early-Stage Vitiligo Study Data
United Therapeutics Stock Rises 14% YTD: Here's What You Need to Know
TVRD Stock Rallies 149% So Far This Week: Here's What You Should Know